Literature DB >> 20166970

Virus vasculopathy and stroke: an under-recognized cause and treatment target.

M A Nagel1, R Mahalingam, R J Cohrs, D Gilden.   

Abstract

While arteriosclerotic disease and hypertension, with or without diabetes, are the most common causes of stroke, viruses may also produce transient ischemic attacks and stroke. The three most-well studied viruses in this respect are varicella zoster virus (VZV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV), all of which are potentially treatable with antiviral agents. Productive VZV infection in cerebral arteries after reactivation (zoster) or primary infection (varicella) has been documented as a cause of ischemic and hemorrhagic stroke, aneurysms with subarachnoid and intracerebral hemorrhage, arterial ectasia and as a co-factor in cerebral arterial dissection. CMV has been suggested to play a role in the pathogenesis of arteriosclerotic plaques in cerebral arteries. HIV patients have a small but definite increased incidence of stroke which may be due to either HIV infection or opportunistic VZV infection in these immunocompromised individuals. Importantly, many described cases of vasculopathy in HIV-infected patients were not studied for the presence of anti-VZV IgG antibody in CSF, a sensitive indicator of VZV vasculopathy. Unlike the well-documented role of VZV in vasculopathy, evidence for a causal link between HIV or CMV and stroke remains indirect and awaits further studies demonstrating productive HIV and CMV infection of cerebral arteries in stroke patients. Nonetheless, all three viruses have been implicated in stroke and should be considered in clinical diagnoses.

Entities:  

Mesh:

Year:  2010        PMID: 20166970      PMCID: PMC2909030          DOI: 10.2174/187152610790963537

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  81 in total

1.  Two patients with unusual forms of varicella-zoster virus vasculopathy.

Authors:  Donald H Gilden; Howard L Lipton; James S Wolf; William Akenbrandt; John E Smith; Ravi Mahalingam; Bagher Forghani
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

2.  Pathogenesis of varicella-zoster angiitis in the CNS.

Authors:  C C Linnemann; M M Alvira
Journal:  Arch Neurol       Date:  1980-04

3.  Selective decline in cellular immune response to varicella-zoster in the elderly.

Authors:  A E Miller
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

4.  Human cytomegalovirus infection in human renal arteries in vitro.

Authors:  Barbara Reinhardt; Bianca Vaida; Rainer Voisard; Lutz Keller; Jürgen Breul; Harald Metzger; Tina Herter; Regine Baur; Anke Lüske; Thomas Mertens
Journal:  J Virol Methods       Date:  2003-04       Impact factor: 2.014

5.  Acquired immunodeficiency syndrome and the risk of stroke.

Authors:  John W Cole; Amelia N Pinto; J Richard Hebel; David W Buchholz; Christopher J Earley; Constance J Johnson; Richard F Macko; Thomas R Price; Michael A Sloan; Barney J Stern; Robert J Wityk; Marcella A Wozniak; Steven J Kittner
Journal:  Stroke       Date:  2003-12-18       Impact factor: 7.914

6.  Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.

Authors:  R Berger; G Florent; M Just
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

Review 7.  The protean manifestations of varicella-zoster virus vasculopathy.

Authors:  Donald H Gilden; Ravi Mahalingam; Randall J Cohrs; Bette K Kleinschmidt-DeMasters; Bagher Forghani
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

8.  Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection.

Authors:  Priscilla Y Hsue; Kamini Giri; Sara Erickson; John S MacGregor; Naji Younes; Amandeep Shergill; David D Waters
Journal:  Circulation       Date:  2004-01-12       Impact factor: 29.690

9.  Multifocal varicella-zoster virus vasculopathy without rash.

Authors:  Andrew N Russman; Richard J Lederman; Leonard H Calabrese; Peter J Embi; Bagher Forghani; Donald H Gilden
Journal:  Arch Neurol       Date:  2003-11

10.  Oligoclonal immunoglobulins in cerebrospinal fluid during varicella zoster virus (VZV) vasculopathy are directed against VZV.

Authors:  Mark P Burgoon; Barbara N Hammack; Gregory P Owens; Amy L Maybach; M Judith Eikelenboom; Donald H Gilden
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

View more
  37 in total

1.  Leg paralysis due to herpes zoster: segmental paralysis or viral vasculopathy and stroke?

Authors:  Ivan Chernev; David Dado
Journal:  Intern Emerg Med       Date:  2013-05-26       Impact factor: 3.397

2.  Varicella zoster virus latency.

Authors:  Emily Eshleman; Aamir Shahzad; Randall J Cohrs
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

3.  HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series.

Authors:  J Gutierrez; G Ortiz
Journal:  Clin Neuroradiol       Date:  2011-07-20       Impact factor: 3.649

4.  Current proceedings of childhood stroke.

Authors:  Hueng-Chuen Fan; Chih-Fen Hu; Chun-Jung Juan; Shyi-Jou Chen
Journal:  Stroke Res Treat       Date:  2011-02-07

5.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

6.  The differences in functional recovery between HIV-positive and HIV-negative stroke survivors.

Authors:  Jenny Janse van Rensburg; Witness Mudzi; Veronica Ntsiea
Journal:  Turk J Phys Med Rehabil       Date:  2018-11-03

7.  Healthcare Worker With Large Vessel Acute Ischemic Stroke Likely Related to Mild SARS-CoV-2 Infection.

Authors:  Carlos Castillo-Pinto; Guillaume Lamotte; Amit Mehta; Rajiv Sonti; Gianluca Di Maria; Daniel Ruiz; Princy N Kumar; Andrew B Stemer; M Carter Denny
Journal:  Neurohospitalist       Date:  2020-11-10

8.  Correlation of Neuroimaging Findings with Clinical Presentation and Laboratory Data in Patients with COVID-19: A Single-Center Study.

Authors:  Seyhmus Kavak; Mehmet Serdar Yildirim; Rojhat Altındag; Yilmaz Mertsoy; Mehmet Fuat Alakus; Mehmet Diyaddin Guleken; Safak Kaya
Journal:  Biomed Res Int       Date:  2021-08-10       Impact factor: 3.411

9.  Stroke-Like Presentation of Toxic Leukoencephalopathy as the Initial Manifestation of HIV Infection.

Authors:  Björn Reuter; Marc E Wolf; Alex Förster; Kira Kalvin; Kristina Szabo; Hansjörg Bäzner; Michael G Hennerici
Journal:  Case Rep Neurol       Date:  2012-12-12

10.  COVID-19 associated nervous system manifestations.

Authors:  Fatima Khatoon; Kartikay Prasad; Vijay Kumar
Journal:  Sleep Med       Date:  2021-07-09       Impact factor: 4.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.